1.
Journal of Leukemia & Lymphoma
;
(12): 321-324, 2010.
Artículo
en Chino
| WPRIM
| ID: wpr-473253
RESUMEN
The treatment for adult refractory /relapsed acute lymphoblastic leukemia is a major challenge in clinical practice. Therapeutic strategies including high-dose single agent,intensified induction,new drugs,targeted therapy,and immunotherapy etc. may be of benefit to some patients. The post-remission treatments remain to be further developed.